Interest in antibacterial nanomaterials has surged due to the growing threat of antibiotic-resistant microbes. A particularly promising strategy involves the use of nanomaterials that generate reactive oxygen species upon exposure to light, effectively combating microorganisms. However, a key challenge lies in translating the properties observed at the molecular level to the material as a whole. Researchers at the University of Duisburg-Essen, led by Junior Professor Dr. Anzhela Galstyan, have made significant progress in addressing this challenge. Using fluorescence lifetime microscopy, they visualised the active sites of these materials for the first time, enabling them to establish correlations between activity and material properties. Their findings were recently published in Angewandte Chemie.
The global nano-biotechnology market is on the brink of remarkable growth, driven by the increasing demand for personalized medicine, an aging population, and groundbreaking advancements in drug delivery, diagnostics, and tissue engineering. This rapidly evolving field holds the potential to revolutionize not just healthcare, but also agriculture and energy sectors. As innovation continues to unfold, nano-biotechnology is set to shape a future with more precise, effective, and sustainable solutions, making it a pivotal force in the world of science and technology.
Nanomaterials, substances with at least one dimension in the nanometer range (1 to 100 nanometers), have shown immense potential across various industries due to their unique properties, such as increased strength, enhanced chemical reactivity, and improved electrical conductivity. As research and technological advancements continue to unfold, nanomaterials are becoming a cornerstone in applications spanning from electronics and healthcare to energy and environmental sectors. The global market for nanomaterials is on a robust growth trajectory, driven by the increasing demand for high-performance materials in numerous industries.
This report explores the key drivers, challenges, trends, and growth opportunities within the global nanomaterials market. The market is forecasted to grow at a compound annual growth rate (CAGR) of 14.4%, with the market value expected to rise from US$12.2 billion in 2024 to US$31.3 billion by 2031.
Researchers at the New Jersey Institute of Technology (NJIT) have unveiled a groundbreaking imaging technology called modulated optically computed phase microscopy (M-OCPM), which allows scientists to visualize the interactions between nanoparticles (NPs) and living cells with exceptional clarity and precision. This novel approach aims to advance the development of nanoparticle-based drug delivery systems, which have shown great promise in medical treatments including targeted therapies and vaccines.
Nanoparticles have gained considerable attention as innovative drug delivery vehicles due to their ability to transport therapeutics directly to targeted sites within the body. Understanding how these particles behave at the cellular level is vitally important, particularly how they interact with cells during processes of absorption and release. Unfortunately, traditional imaging techniques often struggle to provide reliable insights about these interactions due to limitations related to resolution and sensitivity.
A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy, as demonstrated in leukemia models. The study, published in the journal Chem, was led by researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) and Memorial Sloan Kettering Cancer Center.
Drug delivery systems often face two critical challenges: poor solubility and inefficient delivery within the body. Many drugs do not dissolve well, making it difficult for them to reach their intended targets. Furthermore, current delivery systems waste a significant portion of the drug during preparation—only 5–10% of the drug is successfully loaded, leading to less effective treatments.